Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
09/2007
09/18/2007CA2329077C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
09/18/2007CA2236648C Sulfatation of estrogen mixtures
09/18/2007CA2224173C Sunscreen compositions
09/13/2007WO2004103303A3 Therapeutic dental composition
09/13/2007US20070213392 Thiophene and Benzothiophene Hydroxamic Acid Derivatives
09/13/2007US20070213379 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
09/13/2007US20070213344 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213343 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070213342 2-1-Aza-bicyclo[2.2.2]oct-3-yl-6-phenyl-2,3-dihydro-isoindol-1-one, salts and radioactive materials for drug screening; anxiolytic agents; antidepressants; schizophrenia; cognitive activators; attention disorders; Alzheimer's disease; Parkinson's disease; Tourette's syndrome; neuroprotants; analgesics
09/13/2007US20070213312 Hif-1 Inhibitors and Methods of Use Thereof
09/13/2007US20070213299 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on a substrate ( lumber, decking, flooring, roofing, carpets, wallpaper, paneling, cloth caulking etc.); encapsulated, sustained release
09/13/2007US20070213263 Methods And Compositions Using Adiponectin For Treatment Of Cardiac Disorders And For Stimulation Of Angiogenesis
09/13/2007US20070212756 Methods for treating lentivirus infections
09/13/2007US20070212421 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/13/2007US20070212378 Methods And Compositions For Mycoplasma Pneumoniae Exotoxins
09/13/2007US20070212345 Methods And Compositions For The Prevention And Treatment Of Gentiourinary Disorders Including Pre-Term Labor And Leiomyomas
09/12/2007EP1832290A2 Compositions and methods for use in targeting vascular destruction
09/12/2007EP1832279A2 A process for the preparation of suspensions of drug particles for inhalation delivery
09/12/2007EP1830863A2 Protein formulation
09/12/2007EP1599208A4 Antiglucocorticoids for the treatment of postpartum psychosis
09/12/2007EP1372615A4 Compounds and compositions for delivering active agents
09/11/2007US7268213 Glucagon-like peptide-1 (glp-1) receptor agonist
09/11/2007US7268138 Compounds, methods and pharmaceutical compositions for inhibiting PARP
09/11/2007US7267652 Systems and methods for respiratory event detection
09/11/2007CA2247645C Topical compositions comprising an oil-in-water emulsion and a retinoid
09/11/2007CA2188931C Agent for treating cor pulmonale
09/11/2007CA2132736C Topical and transdermal delivery system utilizing submicron oil spheres
09/07/2007WO2007081396A9 Initiators and crosslinkable polymeric materials
09/07/2007WO2005051313A3 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
09/07/2007WO2005037231A3 Methods of detecting and treating facioscapulohumeral muscular dystrophy
09/06/2007US20070208057 Methods And Compositions Using Thalidomide For The Treatment And Management Of Cancers And Other Diseases
09/06/2007US20070208030 Tetrahydroindolone Derivatives for Treament of Neurological Conditions
09/06/2007US20070208020 P70S6 Kinase Modulators And Method Of Use
09/06/2007US20070207967 Peptide Inhibitors of Matrix Metalloproteinase Activity
09/06/2007US20070207953 Host Defense Factor X (HDFX)
09/06/2007US20070207169 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children
09/05/2007EP1578378A4 Absolute quantitation of nucleic acids by rt-pcr
09/05/2007EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives
09/05/2007CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives
09/05/2007CN101028519A Pharmaceutical composition for treating immune diseases
09/05/2007CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
09/05/2007CN100335130C Vaccines
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265128 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/04/2007US7265122 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists
09/04/2007US7265119 For therapy of nicotine dependency
09/04/2007US7264819 Administering methioninase with antibiotics (pentamidine, trimethoprim and/or sulfamethoxazole); Pneumocystis carinii (P.carinii); kits
08/2007
08/30/2007WO2005023203A3 Transition state analog inhibitors of ricin a-chain
08/30/2007US20070203184 Novel Indolin-2-one Derivatives, Their Preparation and the Pharmaceutical Compositions Comprising Them
08/30/2007US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
08/30/2007US20070203071 Conformationally Constrained Parthyroid Hormone (Pth) Analogs
08/30/2007US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them
08/30/2007US20070202208 Anti-Inflammatory Pharmaceutical Compositions For Reducing Inflammation And The Treatment Or Prevention Of Gastric Toxicity
08/30/2007US20070202199 Compositions for Enhancing Sexual Responsiveness
08/30/2007US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof
08/30/2007US20070202170 Dual-release compositions of a cyclooxygenase-2 inhibitor
08/30/2007US20070202158 Methods Of Administering Water-Soluble Prodrugs Of Propofol For Extended Sedation
08/30/2007US20070202133 BENZIMIDAZOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
08/30/2007US20070202131 Use Of Mycrobacterial Vaccines In Cd4+ Or Cd8+ Lymphocyte-Deficient Mammals
08/30/2007US20070202104 Treatment of spondyloarthropathies using TNFalpha inhibitors
08/30/2007US20070202040 Supplying radionuclide to blood clot; ultrasonic imaging; diagnosis, therapy
08/29/2007EP1590344A4 Anti-cancer medicaments
08/28/2007US7262279 A lactoferrin having an N-terminal lactoferrin variant in combination with an effective amount of an antidiabetic drug useful for decreaing blood levels of glucose and insulin thereby treating diabetes mellitus. monitoring the level of glycosylated hemoglobin (HbA1c); delayed release; hyperglycemia
08/28/2007US7262213 Administering (-)-(2S,4S)-1-(2-Hydroxymethyl-1,3-dioxolan-4-yl)cytosine (also referred to as (-)-OddC) for therapy of cancer such as non-small cell lung cancer, colon cancer, breast cancer, prostate cancer, ovarian cancer, leukemia, CNS cancer, melanoma, renal cancer, and lymphoma cancer
08/28/2007US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts
08/28/2007US7262050 Humanised antibodies
08/28/2007US7261889 Local anesthetic methods and kits
08/28/2007US7261882 Delivering antiinflammatory cytokines to nervous system using gene therapy techniques
08/28/2007US7261769 Stabilized anthocyanin extract from Garcinia indica
08/23/2007US20070197637 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
08/23/2007US20070197624 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease
08/23/2007US20070197601 Use of N-[Phenyl(piperidin-2-yl)methyl]benzamide derivatives in therapy
08/23/2007US20070197577 Inhibitors of anthrax lethal factor
08/23/2007US20070197468 Oral formulations of cladribine
08/23/2007US20070196857 Determination of risk and treatment of complications of prematurity
08/23/2007US20070196433 Methods and devices for the sustained release of multiple drugs
08/23/2007US20070196418 Drug delivery methods and devices
08/23/2007US20070196347 Methods for preventing neurological events
08/23/2007US20070196316 Stimulation Of Hair Growth By Ginkgo Biloba Flavanoids
08/22/2007EP1819755A1 Polymeric nano-shells
08/22/2007EP1641422A4 Interleukin-21 analogs
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007CN1332648C Microemulsion preconcentrate
08/22/2007CN101022784A Infusion and injection solution of levodopa
08/21/2007US7259170 Macrolides containing pharmaceutical compositions
08/21/2007US7259160 Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
08/21/2007US7259151 AAV virions with decreased immunoreactivity and uses therefor
08/21/2007US7259150 Oligonucleotides; nucleic acid; therapy, diagnosis; cardiovascular disorders, atherosclerosis, anticholesterol agents
08/21/2007US7258861 Peptides derived from the region of human TNF- alpha from Ser100 to Glu116 to treat pulmonary oedema.
08/16/2007WO2007092161A2 A direct cellular energy delivery system
08/16/2007WO2005027835A3 Therapeutic immunization of hiv-infected individuals
08/16/2007WO2004103283A3 Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
08/16/2007WO2004089294A3 Compositions, methods and kits relating to her-2 cleavage
08/16/2007WO2004071461A3 Tra16 a tr4/tr2 repressor
08/16/2007WO2004064763A3 Cleavage of serum response factor in cardiac diagnosis and therapy
08/16/2007WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer
08/16/2007WO2004009029A3 Compositions and methods for treating and preventing infection
08/16/2007US20070190644 With vaccinia virus complement control protein, poxvirus encoded
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 295